-
1
-
-
0344497646
-
A bacterologic study of erythemal nodosum lepsroum
-
Ridley DS. A bacterologic study of erythemal nodosum lepsroum. Int J Lepr Other Mycobacterial Dis. 1960;28:254-266.
-
(1960)
Int J Lepr Other Mycobacterial Dis
, vol.28
, pp. 254-266
-
-
Ridley, D.S.1
-
2
-
-
0020966257
-
The immunopathology of erythema nodosum leprosum: The role of extravascular complexes
-
Ridley MJ, Ridley DS. The immunopathology of erythema nodosum leprosum: The role of extra-vascular complexes. Lepr Rev. 1983;54:95-107. (Pubitemid 13046647)
-
(1983)
Leprosy Review
, vol.54
, Issue.2
, pp. 95-107
-
-
Ridley, M.J.1
Ridley, D.S.2
-
4
-
-
0019303422
-
Kellersberger Memorial Lecture 1979: immunosuppressive/anti-inflammatory thalidomide analogues
-
Hastings, RC. Kellersbergerer Memorial Lecture 1979: Immunosuppressive/ Anti-inflammatory Thalidomide Analogs. Ethiop Med J. 1980;18:65-71. (Pubitemid 10028119)
-
(1980)
Ethiopian Medical Journal
, vol.18
, Issue.2
, pp. 65-71
-
-
Hastings, R.C.1
-
5
-
-
0014610169
-
Erythema nodosum leprosum: A clinical manifestation of the arthus phenomenon
-
Wemambu SN, Turk JL, Waters MF, Rees RJ. Erythema nodosum leprosum: A clinical manifestation of the arthus phenomenon. Lancet. 1969;2:933-935.
-
(1969)
Lancet
, vol.2
, pp. 933-935
-
-
Wemambu, S.N.1
Turk, J.L.2
Waters, M.F.3
Rees, R.J.4
-
6
-
-
0017027591
-
Immune complexes and complement hypercatabolism in patients with leprosy
-
Bjorvatn B, Barnetson RS, Kronvall G, Zubler RH, Lamber PH. Immune complexes and complement hypercatabolism in patients with leprosy. Clin exp Immuno. 1976;26:388-396.
-
(1976)
Clin Exp Immuno
, vol.26
, pp. 388-396
-
-
Bjorvatn, B.1
Barnetson, R.S.2
Kronvall, G.3
Zubler, R.H.4
Lamber, P.H.5
-
7
-
-
0020662025
-
Breakdown product of Factor B as an index to complement activation in lepromatous leprosy and its relation to bacillary load
-
Saha K, Sharma V, Chakrabarty AK, Sehgal VN. Breakdown product of Factor B as an index to complement activation in lepromatous leprosy and its relation to bacillary load. Scand J Immunol. 1983;17:253-260.
-
(1983)
Scand J Immunol
, vol.17
, pp. 253-260
-
-
Saha, K.1
Sharma, V.2
Chakrabarty, A.K.3
Sehgal, V.N.4
-
8
-
-
0030897450
-
Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-α
-
DOI 10.1016/S0162-3109(96)00154-3, PII S0162310996001543
-
Shannon EJ, Sandoval FG, Krahenbuhl. Hydrolysis of thalidomide abrogates its ability to enhance mononuclear cell synthesis of IL-2 as well as its ability to suppress the synthesis of TNF-α. Immunopharmacolog. 1997;36:9-15. (Pubitemid 27153473)
-
(1997)
Immunopharmacology
, vol.36
, Issue.1
, pp. 9-15
-
-
Shannon, E.J.1
Sandoval, F.2
Krahenbuhl, J.L.3
-
9
-
-
45849144796
-
Thalidomide and thalidomide transformed by pH-dependent hydrolysis or by liver enzyme treatment does not impede the proliferation of endothelial cells
-
DOI 10.1080/08923970801925406, PII 793332038
-
Shannon EJ, Sandoval FG. Thalidomide and thalidomide transformed by pH-dependent hydrolysis or by liver enzyme treatment does not impede the proliferation of endothelial cells. Immunopharmcol and Immunotoxico. 2008;30:307-316. (Pubitemid 351882918)
-
(2008)
Immunopharmacology and Immunotoxicology
, vol.30
, Issue.2
, pp. 307-316
-
-
Shannon, E.J.1
Sandoval, F.G.2
-
10
-
-
33746445556
-
Effects of purification and fluorescent staining on viability of Mycobacterium leprae
-
Lahiri R, Randhawa B, Krahenbuhl JL. Effects of purification and fluorescent staining on viability of Mycobacterium leprae. Int J Lepr Other Mycobacterial Dis. 2005;73:194-202.
-
(2005)
Int J Lepr Other Mycobacterial Dis
, vol.73
, pp. 194-202
-
-
Lahiri, R.1
Randhawa, B.2
Krahenbuhl, J.L.3
-
11
-
-
0002630748
-
Complement and complement fixation
-
Kabat EA, ed. 2nd ed. Springfield, ILL: Charles C. Thomas
-
Mayer MM. Complement and complement fixation. In: Kabat EA, ed. Kabat and Mayer's Experimental Immunochemistry. 2nd ed. Springfield, ILL: Charles C. Thomas; 1961.
-
(1961)
Kabat and Mayer's Experimental Immunochemistry
-
-
Mayer, M.M.1
-
12
-
-
0005413570
-
-
PhD thesis. Sweden: Department of Clinical Pharmacology, Lund University, Lund and Hospital Pharmacy, Malmö University Hospital
-
Eriksson T. Pharmacokinetics of the Enantiomers of Thalidomide. [PhD thesis]. Sweden: Department of Clinical Pharmacology, Lund University, Lund and Hospital Pharmacy, Malmö University Hospital; 1997.
-
(1997)
Pharmacokinetics of the Enantiomers of Thalidomide
-
-
Eriksson, T.1
-
13
-
-
35349001343
-
Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia
-
DOI 10.1016/j.trsl.2007.05.003, PII S1931524407001466
-
Shannon EJ, Noveck R, Sandoval FG, Kamath B, Kearney M. Thalidomide suppresses interleukin-6 but not tumor necrosis factoralpha in volunteers with experimental endotoxemia. Translational Research. 2007;150:275-280. (Pubitemid 47615635)
-
(2007)
Translational Research
, vol.150
, Issue.5
, pp. 275-280
-
-
Shannon, E.1
Noveck, R.2
Sandoval, F.3
Kamath, B.4
Kearney, M.5
-
14
-
-
0033985996
-
Evaluation of the developmental toxicity of thalidomide using Frog Embryo Teratogenesis Assay - Xenopus (FETAX): Biotransformation and detoxification
-
DOI 10.1002/(SICI)1520-6866(2000)20:1<35::AID-TCM4>3.0.CO;2-I
-
Fort D, Stover E, Bantle J, Finch R. Evaluation of the development toxicity of thalidomide using frog embryo teratogenesis assay-Xenopus (FETAX): Biotransformation and detoxification. Teratog Carcinog Mutagen. 2000;20:35-47. (Pubitemid 30036159)
-
(2000)
Teratogenesis Carcinogenesis and Mutagenesis
, vol.20
, Issue.1
, pp. 35-47
-
-
Fort, D.J.1
Stover, E.L.2
Bantle, J.A.3
Finch, R.A.4
-
15
-
-
12544252992
-
Effects of thalidomide on intracellular Mycobacterium leprae in normal and activated macrophages
-
Tadesse A, Shannon EJ. Effects of thalidomide on intracellular Mycobacterium leprae in normal and activated macrophages. Clin Diagn Lab Immunol. 2005;12:130-134.
-
(2005)
Clin Diagn Lab Immunol.
, vol.12
, pp. 130-134
-
-
Tadesse, A.1
Shannon, E.J.2
-
16
-
-
56449121701
-
Activation of complement by Mycobacterium leprae requires disruption of the bacilli
-
Lahiri R, Sandoval FG, Krahenbuhl JL, Shannon EJ. Activation of complement by Mycobacterium leprae requires disruption of the bacilli. Lepr. Rev. 2008;79:311-314.
-
(2008)
Lepr. Rev.
, vol.79
, pp. 311-314
-
-
Lahiri, R.1
Sandoval, F.G.2
Krahenbuhl, J.L.3
Shannon, E.J.4
-
17
-
-
34347400796
-
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo
-
DOI 10.1182/blood-2006-12-063636
-
Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, Lambris JD, Wetsel RA, Miwa T, Song WC. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood. 2007;110:228-236. (Pubitemid 47026839)
-
(2007)
Blood
, vol.110
, Issue.1
, pp. 228-236
-
-
Zhang, X.1
Kimura, Y.2
Fang, C.3
Zhou, L.4
Sfyroera, G.5
Lambris, J.D.6
Wetsel, R.A.7
Miwa, T.8
Song, W.-C.9
-
18
-
-
0033871601
-
Current views on reaction in leprosy
-
Naafs B. Current views on reaction in leprosy. Indian J. Lepr. 2000;72:97-122.
-
(2000)
Indian J. Lepr.
, vol.72
, pp. 97-122
-
-
Naafs, B.1
-
19
-
-
40249089742
-
Towards understanding the pathology of erythema nodosum leprosum
-
Kahawita IP, Lockwood DN. Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg. 2008;102(4):329-337.
-
(2008)
Trans R Soc Trop Med Hyg.
, vol.102
, Issue.4
, pp. 329-337
-
-
Kahawita, I.P.1
Lockwood, D.N.2
|